Escherichia coli O157 and human disease

Current Opinion in Infectious Diseases

Volumn 11, Issue 2, 1998, Pages 171-175

  Dundas, Stephanie ^a   Todd, W T Andrew ^a  

^a MONKLANDS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL VIRULENCE; CLINICAL FEATURE; DISEASE SEVERITY; ESCHERICHIA COLI O157; FECES ANALYSIS; GRAM NEGATIVE INFECTION; HUMAN; INDUSTRIALIZATION; PUBLIC HEALTH; REVIEW; SERODIAGNOSIS;

EID: 0031969752     PISSN: 09517375     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001432-199804000-00015     Document Type: Review

References (56)

1. Armstrong GL, Hollingsworth J, Morris JG. Emerging foodborne •• pathogens: Escherichia coli O157 : H7 as a model of entry of a new pathogen into the food supply of the developed world. Epidemiol Rev 1996; 18:29-51.
2. Riley LW, Remis RS, Helgerson SD. Haemorrhagic colitis associated with a rare Escherichia coll serotype. N Engl J Med 1983; 308:681-685.
3. Gutteriaz E. Japan prepares as O157 strikes again [news]. Lancet 1997; 349:1156.
4. Scottish Centre for Infection and Environmental Health. Outbreak of Escherichia coli O157 infection. Weekly Epidemiol Rec 1997; 3:14-15.
5. Day NP, Scotland SM, Cheasty T. Escherichia coli O157 : H7 associated with human infections in the United Kingdom [letter]. Lancet 1983; 1:825.
6. Griffin PM, Ostroff SM, Tauxe RV, Greene KD. Illnesses associated with Escherichia coli O157 : H7 Infections. Ann Intern Med 1988; 109:705-712.
7. Mead PS, Finelli L, Lambert-Fair MA, Champ D, Townes J, Hutwanger L, et al. Risk factors for sporadic infection with Escherichia coli O157 : H7. Arch Intern Med 1997; 157:204-208.
8. Wall PG, McDonnell RJ, Adak GK, Cheasty T, Smith HR, Rowe B. General outbreaks of Vero cytotoxin producing Escherichia coli in England and Wales from 1992 to 1994. CDR Rev 1996; 6:R26-R33.
9. Djuretic T, Wall PG, Nichols G. General outbreaks of infectious intestinal diseases associated with milk and dairy products in England and Wales: 1992-1996. CDR Rev 1997; 7:R41-R45.
10. Chapman PA, Siddons CA, Harkin MA. Sheep as a potential source of verocytotoxin-producing Escherichia coli O157 [letter], Vet Rec 1996; 138:23-24.
11. Reymond D, Johnson RP, Karmali MA, Petric M, Winkler M, Johnson S, et al., Neutralising antibodies to Escherichia coli Vero Cytotoxin 1 and antibodies to O157 lipopolysaccharide in healthy farm family members and urban residents. J Clin Microbiol 1996; 34:2053-2057.
12. Robins-Browne RM. Enterohaemorrhagic Escherichia coli: an emerging food-borne pathogen with serious consequences. Med J Aust 1995; 162:511-512.
13. Anonymous, Centers for Disease Control. Outbreak of Escherichia coli O157 : H7 infections in association with drinking unpasteurised commercial apple juice - British Columbia, California, Colorado and Washington. October 1996; MMWR 1996; 44:975.
14. Shah S, Hoffman R, Shillmam P, Wilson B. Prolonged faecal shedding of Escherichia coli O157 : H7 during an outbreak in a day care centre. Clin Infect Dis 1996; 23:835-886.
15. Belongia EA, Osterholm MT, Soler JT, Ammend DA, Braun JE, MacDonald KL. Transmission of Escherichia coli O157 : H7 in Minnesota child day-care facilities. JAMA 1993; 269:883-888.
16. Griffin PM, Tauxe RV. The epidemiology of infections caused by Escherichia coli O157 : H7, other enterohaemorrhagic E. coli, and the associated haemolytic uraemic syndrome. Epidemiol Rev 1991; 13:60-98.
17. Slutsker L, Ries AA, Greene KD, Wells JG, Hutwagner L, Griffin PM. •• Escherichia coli O157 : H7 diarrhoea in the United States: clinical and epidemiological features. Ann Intern Med 1997; 126:505-513.
18. Advisory Committee of the Microbiological Safety of Food. Report on verocytotoxin-producing Escherichia coli. London: HMSO; 1995.
19. Tarr PI, Neill MA, Clausen CR, Watkins SL, Christie DL, Hickman RO. Eschenchia coli O157 : H7 and the haemolytic uraemic syndrome: importance of early cultures in establishing the aetiology. J Infect Dis 1990; 162:553-556.
20. Karch H, Janetzki-Mittmaann C, Aleksic S, Datz M. Isolation of enterohaemorrhagic Eschenchia coli O157 strains from patients with haemolytic-uraemic syndrome by using immunomagnetic separation, DNA-based methods, and direct culture. J Clin Microbiol 1996; 34:516-519.
21. Karch H. Verocytotoxin producing Escherichia coli infection in Europe: Diagnosis and public health perspectives. In: Recent advances in verocytotoxin-producing Escherichia coli infections. Karmali MA, Golgio AG, (editors). Amsterdam: Elsevier Science BV; 1994. pp. 13-16.
22. Notenbbom RH, Borczyk A, Karmali MA, Duncan LMC. Clinical relevance of a serological cross-reaction between Escherichia coli O157 and Brucella abortus. Lancet 1987; ii:745.
23. Bitzan M, Karch H. Indirect hemagglutination assay for diagnosis of Escherichia coli O157 infection in patients with hemolytic-uremic syndrome. J Clin Microbiol 1992; 30:1174-1176.
24. Chart H, Smith HR, Scotland SM, Rowe W, Milford DV, Taylor CM. Serological identification of Escherichia coli O157 : H7 infection in haemolytic uraemic syndrome. Lancet 1991; 337:138-140.
25. Arbus GS. Association of verotoxin-producing E. coli and verotoxin with •• haemolytic uraemic syndrome. Kidney Int 1997; 51 (suppl 58) :S91-96.
26. Griffin PM, Olmsted LC, Petras RE. Escherichia coli O157 : H7-associated colitis. Gastroenterology 1990; 99:142-149.
27. Morris KP, Coulthard MG, Rangecroft L. Oesophageal and severe gut involvement in the haemolytic uraemic syndrome. Br J Surg 1991; 78:1469-1472.
28. Spika JS. Parsons JE, Nordenberg D, Wells JG. Haemolytic uraemic syndrome and diarrhoea associated with Escherichia coli O157 : H7 in a day centre. Paediatrics 1986; 109:287-291.
29. Anonymous . Thrombotic thrombocytopaenic purpura associated with Eschenchia coli O157 : H7 - Washington. MMWR 1986; 35:549-551.
30. Tzipori S, Karch H, Wachsmuth KI, Robins-Browne RM, O'Brien AD, Lior H, et al. Role of a 60-megadalton plasmid and Shiga-like toxins in the pathogenesis of infection caused by the enterohaemorrhagic Eschenchia coli O157 : H7 in gnotobiotic piglets. Infect Immun 1987; 55:3117-3125.
31. Tzipori S, Wachsmuth IK, Chapman R, Birner J, Brittingham J, Jackson C, Hogg J. The pathogenesis of haemorrhagic colitis caused by Escherichia coli O157 : H7 in gnotobiotic piglets. J Infect Dis 1986; 154:712-716.
32. Tesh VL, O'Brien AD. The pathogenic mechanisms of Shiga toxin and the Shiga-like toxins. Mol Microbiol 1991; 5:1817-1822.
33. Jarvis KG, Kaper JB. Secretion of extracellular proteins by enterohemorrhagic Escherichia coli via a putative type III secretion system. Infect Immun 1996; 64:4826-4829.
34. Waddell TE, Gyles CL. Sodium deoxycholate facilitates systemic absorption of verotoxin 2e from pig intestine. Infect Immun 1995; 63:4953-4956.
35. Lingwood CA. Verotoxin-binding in human renal sections. Nephron 1994; 66:21-28.
36. Obrig TG, Louise CB, Lingwood CA, Boyd B, Barley-Maloney L. Endothelial heterogeneity in Shiga toxin receptors and responses. J Biol Chem 1993; 268:15484-15488.
37. Robinson LA, Hurley RM, Lingwood C, Matsell DG. Escherichia coli verotoxin binding to human paediatric glomerular mesangial cells. Paediatr Nephrol 1995; 9:700-704.
38. Boyd B, Lingwood CA. Verotoxin receptor glycolipid in human renal tissue. Nephron 1989; 51:207-210.
39. Boyd B, Magnusson G, Zhiuyan Z, Lingwood CA. Lipid modulation of glycolipid receptor function - availability of gal μl-4 Gal disaccharide for verotoxin binding in natural and synthetic glycolipids. Eur J Biochem 1994; 223:873-878.
40. Kaye SA, Louise CB, Boyd B, Lingwood CA, Obrig TG. Shiga toxin-associated haemolytic uremic syndrome: interleukin-1 enhancement of shiga toxin toxicity toward human vascular endothelial cells in vitro. Infect Immun 1993; 61:3886-3891.
41. Noris M, Ruggenenti P, Todeschini M, Figliuzzi M, Macconi D, ZoJa C, ef al. Increased nitric oxide formation in recurrent thrombotic microangiopathies: a possible mediator of microvascular injury. Am J Kidney Dis 1996; 27:790-796.
42. Remuzzi G, Ruggenenti P. The haemolytic uremic syndrome. (Perspectives in Clinical Nephrology). Kidney Int 1995; 47:2-19.
43. Hertzke DM, Cowan LA, Schonong P, Fenwick BW. Glomerular ultrastructural lesions of idiopathic cutaneous and renal glomerular vasculopathy of greyhounds. Vet Patnol 1995; 32:451-459.
44. Swerdlow DL, Woodruff BA, Brady RC, Griffin PM, Tippen S, Donnel H, et al, A waterborne outbreak in Missouri of Escherichia coli: O157 : H7 associated with bloody diarrhoea and death (see comments). Ann Intern Med 1992; 121:299-303.
45. Pavia AT, Craig R, Nichols CR, Green DP. Haemolytic uraemic syndrome during an outbreak of Escnerichia coli O157 : H7 infections in institutions for mentally retarded persons: clinical and epidemiological observations. J Paediatr 1990; 116:544-551.
46. Proulx F, Turgoen JP, Delage G, Lafleur L, Chicoine L. Randomised controlled trial of antibiotic therapy for Escherichia coli O157 : H7 enteritis. J Paediatr 1992; 121:299-303.
47. Wolf LE, Acheson DW, Lincicome LL, Keusch GT. Subinhibitory concentrations of antibiotics increase the release of Shiga toxin from E. coli O157 : H7 in vitro. Abstracts from VTEC 97, Baltimore, 1997.
48. Yoh M, Huda T. Fosfomycin increases release of verotoxin. Epidemiol Infect 1997; 119:101-103.
49. Ruggenenti P, Lutz J, Remuzzi G. Pathogenesis and treatment of thrombotic microangiopathy. Kidney Int 1997; 51 (suppl 58):S97-101.
50. Carter AO, Borczyk AA, Carlson JAC, Harvey B, Hockin JC, Karmali MA. A severe outbreak of Escherichia coli 0157 : H7-associated haemorrhagic colitis in a nursing home. N Engl J Med 1987; 24:1496-1500.
51. Tsuji A, Sasaki M, Kanemitsu T, Uehara N, Hiroshi I, Honda M. Hemolytic uremic syndrome following haemorrhagic colitis caused by verocytotoxin-producing Eschericnia coli O157 : H7: early signs of hemolytic uremic syndrome. Keio J Med 1996; 45:44-47.
52. Lindsay JA. Chronic sequelae of foodborne disease. Emerg Infectious Dis 1997; 3:443-452.
53. Fitzpatrick M, Shah V, Trompeter R, Dhillon M. Long term outcome after childhood haemolytic uraemic syndrome. BMJ 1991; 303:489-492.
54. Caletti MG, Gallo G, Gianantonio CA. Development of focal segmental • sclerosis and hyalinosis in hemolytic uremic syndrome. Paediatr Nephrol 1996; 10:687-692.
55. Brandt JR, Joseph MW, Tarr PL, Watkins SL. Late gastrointestinal and renal sequelae following an outbreak of E. coli 0157 : H7-associated HUS in Washington state. Abstracts from VTEC 97, Baltimore, 1997.
56. The Pennington Group. Report on the circumstances leading to the 1996 outbreak of infection with E. coli O157 in Central Scotland, the implications for food safety and lessons to be learned. Edinburgh: The Stationery Office; 1997.